283 related articles for article (PubMed ID: 4082245)
1. Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.
Bertilsson L; Aberg-Wistedt A; Gustafsson LL; Nordin C
Ther Drug Monit; 1985; 7(4):478-80. PubMed ID: 4082245
[No Abstract] [Full Text] [Related]
2. Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.
Sjöqvist F; Bertilsson L
Prog Clin Biol Res; 1986; 214():169-88. PubMed ID: 3523507
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio.
Nordin C; Siwers B; Benitez J; Bertilsson L
Br J Clin Pharmacol; 1985 Jun; 19(6):832-5. PubMed ID: 4027124
[TBL] [Abstract][Full Text] [Related]
4. Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients.
Solai LK; Pollock BG; Mulsant BH; Frye RF; Miller MD; Sweet RA; Kirshner M; Sorisio D; Begley A; Reynolds CF
J Clin Psychopharmacol; 2002 Oct; 22(5):481-6. PubMed ID: 12352271
[TBL] [Abstract][Full Text] [Related]
5. Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin.
Baumann P; Jonzier-Perey M; Koeb L; Küpfer A; Tinguely D; Schöpf J
Int Clin Psychopharmacol; 1986 Apr; 1(2):102-12. PubMed ID: 3571939
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of tricyclic antidepressants on lumbar spinal stenosis.
Orbai AM; Meyerhoff JO
Bull NYU Hosp Jt Dis; 2010; 68(1):22-4. PubMed ID: 20345358
[TBL] [Abstract][Full Text] [Related]
7. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
Lydiard RB
J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics of antidepressant metabolism. Value of the debrisoquin test].
Baumann P
Encephale; 1986; 12(4):143-8. PubMed ID: 3792273
[TBL] [Abstract][Full Text] [Related]
9. Initiation of tricyclic treatment at full dose.
Nelson JC
J Clin Psychiatry; 1994 Jun; 55(6):266-7. PubMed ID: 8071287
[No Abstract] [Full Text] [Related]
10. Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man.
Bertilsson L; Eichelbaum M; Mellström B; Säwe J; Schulz HU; Sjöqvist F
Life Sci; 1980 Nov; 27(18):1673-7. PubMed ID: 7442467
[No Abstract] [Full Text] [Related]
11. Treating delusional depressives with amitriptyline.
Spiker DG; Dealy RS; Hanin I; Weiss JC; Kupfer DJ
J Clin Psychiatry; 1986 May; 47(5):243-6. PubMed ID: 3516978
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations.
von Bahr C; Birgersson C; Morgan ET; Eriksson O; Göransson M; Spina E; Woodhouse K
Xenobiotica; 1986 May; 16(5):391-400. PubMed ID: 3739365
[TBL] [Abstract][Full Text] [Related]
13. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice.
Rubin EH; Biggs JT; Preskorn SH
J Clin Psychiatry; 1985 Oct; 46(10):418-24. PubMed ID: 3900052
[TBL] [Abstract][Full Text] [Related]
14. E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
Mellström B; Bertilsson L; Säwe J; Schulz HU; Sjöqvist F
Clin Pharmacol Ther; 1981 Aug; 30(2):189-93. PubMed ID: 7249504
[TBL] [Abstract][Full Text] [Related]
15. [The use of low-dose amitriptyline in psychogeriatrics. A clinical, pharmacokinetic and pharmacogenetic study].
Schnyder C; Baumann P; Jonzier-Perey M; Koeb L; Wertheimer J
Schweiz Med Wochenschr; 1985 Aug; 115(33):1128-34. PubMed ID: 4035330
[TBL] [Abstract][Full Text] [Related]
16. Tricyclic antidepressants: clinical use of plasma levels.
Preskorn SH; Madakasira S
J Kans Med Soc; 1981 Mar; 82(3):122-4, 134. PubMed ID: 7276685
[No Abstract] [Full Text] [Related]
17. Clinical pharmacology of antidepressant drugs: pharmacogenetics.
Sjöqvist F; Bertilsson L
Adv Biochem Psychopharmacol; 1984; 39():359-72. PubMed ID: 6380229
[TBL] [Abstract][Full Text] [Related]
18. Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.
Woolhouse NM; Adjepon-Yamoah KK; Mellström B; Hedman A; Bertilsson L; Sjöqvist F
Clin Pharmacol Ther; 1984 Sep; 36(3):374-8. PubMed ID: 6467797
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic hydroxylation of debrisoquine.
Tucker GT; Silas JH; Iyun AO; Lennard MS; Smith AJ
Lancet; 1977 Oct; 2(8040):718. PubMed ID: 71525
[No Abstract] [Full Text] [Related]
20. Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications.
Bertilsson L; Mellström B; Sjökvist F; Mårtenson B; Asberg M
Lancet; 1981 Mar; 1(8219):560-1. PubMed ID: 6111662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
